AstraZeneca may have released outdated information on its latest COVID-19 vaccine trial, giving an ”incomplete” picture of its efficacy, a leading U.S. health agency said on Tuesday, casting doubt on the shot’s potential U.S. rollout and plunging…
AstraZeneca may have provided incomplete efficacy data from latest COVID-19 trial: NIAID
